🇪🇬 Country Profile

Egypt

Expanding pharmaceutical supply to Egypt

🇪🇬 $202M
All data from DGCIS India export records (fiscal year, April–March).
$202M
Scale
Egypt's healthcare system receives $202M in Indian pharmaceutical products each year, affordable, quality medicine.
67%
Medicine
Primarily medicine ingredients (67%), supplemented by medicines and vaccines.
2.2×
Trajectory
India's pharmaceutical supply to Egypt has grown 2.2× over the past decade, strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Africa.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Egypt, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicine Ingredients $135M (67.1%) Medicines $32.8M (16.2%) Vaccines $24.1M (11.9%) Surgical & Hospital Supplies $8.1M (4.0%) Traditional & Herbal $1.4M (0.7%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Egypt Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Egypt: $8.3M across 25 filings (2011-2022).